We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Molecular docking and ligand specificity in fragment-based inhibitor discovery.
- Authors
Yu Chen; Shoichet, Brian K.
- Abstract
Fragment screens have successfully identified new scaffolds in drug discovery, often with relatively high hit rates (5%) using small screening libraries (1,000–10,000 compounds). This raises two questions: would other noteworthy chemotypes be found were one to screen all commercially available fragments (>300,000), and does the success rate imply low specificity of fragments? We used molecular docking to screen large libraries of fragments against CTX-M β-lactamase. We identified ten millimolar-range inhibitors from the 69 compounds tested. The docking poses corresponded closely to the crystallographic structures subsequently determined. Notably, these initial low-affinity hits showed little specificity between CTX-M and an unrelated β-lactamase, AmpC, which is unusual among β-lactamase inhibitors. This is consistent with the idea that the high hit rates among fragments correlate to a low initial specificity. As the inhibitors were progressed, both specificity and affinity rose together, yielding to our knowledge the first micromolar-range noncovalent inhibitors against a class A β-lactamase.
- Publication
Nature Chemical Biology, 2009, Vol 5, Issue 5, p358
- ISSN
1552-4450
- Publication type
Academic Journal
- DOI
10.1038/nchembio.155